Abstract:Rottlerin is a key bioactive phytoconstituent present in the pericarp of Mallotus philippensis. It shows promising multifaceted pharmacological actions against cancer. However, there is hardly any report for the quantification of rottlerin in the biological matrix and on its pharmacokinetic behavior. Therefore, we aimed in the present study to assess selective in vitro ADME properties and in vivo pharmacokinetics of isolated and characterized rottlerin using a newly developed and validated liquid chromatography-tandem mass spectrometry-based highly sensitive bioanalytical method. The method was found to be simple (mobile phase and analytical column), sensitive (1.9 ng/mL), and rapid (run time of 2.5 min). All the validation parameters were within the acceptable criteria of the United States Food and Drug Administration's bioanalytical method validation guideline. The method was found to be very useful to assess lipophilicity, plasma stability, metabolic stability, plasma protein binding of rottlerin, as well as its oral and intravenous pharmacokinetics in mice. Rottlerin showed a number of drug-like pharmacokinetic properties (in vitro). Moreover, it displayed an excellent half-life (>2 h) and oral bioavailability (>35%) as compared to other members of natural phenolics. The present study is the first-time report of in vitro ADME properties and in vivo preclinical pharmacokinetics of rottlerin. The generated information is very much useful for its further development as a phytotherapeutics toward cancer therapy.

What problem does this paper attempt to address?

The main issue this paper attempts to address is the evaluation of the pharmacokinetic properties of the bioactive compound Rottlerin extracted from the horse chestnut tree (*Mallotus philippensis*). Specifically, the study aims to develop and validate a highly sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for determining the concentration of Rottlerin in mouse plasma, and to assess the in vivo pharmacokinetic behavior and in vitro absorption, distribution, metabolism, and excretion (ADME) properties of Rottlerin using this method. ### The main research contents include: 1. **Development and validation of the LC-MS/MS method**: The study developed a simple, sensitive, and rapid LC-MS/MS method for determining the concentration of Rottlerin in mouse plasma. The detection limit of this method is as low as 1.9 ng/mL, and the run time is only 2.5 minutes. 2. **Evaluation of the in vitro ADME properties of Rottlerin**: - **Lipophilicity**: The log D value of Rottlerin was determined by the shake flask method, indicating moderate lipophilicity. - **Plasma stability**: In mouse plasma, Rottlerin showed almost no degradation within 2 hours, indicating high plasma stability. - **Metabolic stability**: Rottlerin exhibited high metabolic stability in human liver microsomes (HLMs) and mouse liver microsomes (MLMs). - **Plasma protein binding rate**: The plasma protein binding rate of Rottlerin was measured to be 99.96% using the rapid equilibrium dialysis (RED) method, indicating a high degree of binding to plasma proteins. 3. **Evaluation of the in vivo pharmacokinetics of Rottlerin**: - **Oral bioavailability**: In male Balb/C mice, after oral and intravenous administration at doses of 4 mg/kg and 1 mg/kg respectively, the half-life of Rottlerin exceeded 2 hours, and the oral bioavailability reached 35-36%. - **Pharmacokinetic parameters**: The study determined the main pharmacokinetic parameters of Rottlerin, such as maximum plasma concentration (Cmax), time to reach peak concentration (Tmax), and area under the concentration-time curve (AUC). ### Significance of the study: This is the first report on the LC-MS/MS bioanalytical method and pharmacokinetic behavior of Rottlerin. Rottlerin exhibits good pharmacokinetic properties, particularly in terms of lipophilicity, plasma stability, metabolic stability, and oral bioavailability. These results provide important foundational data for the further development of Rottlerin as an anticancer phytomedicine.

Pharmacokinetic Assessment of Rottlerin from Mallotus philippensis Using a Highly Sensitive Liquid Chromatography–Tandem Mass Spectrometry-Based Bioanalytical Method

Rottlerin As a Therapeutic Approach in Psoriasis: Evidence from in Vitro and in Vivo Studies.

Biopharmacological Considerations for Accelerating Drug Development of Deguelin, a Rotenoid with Potent Chemotherapeutic and Chemopreventive Potential

Reversed-phase high-performance Liquid Chromatography-ultraviolet Photodiode Array Detector Validated Simultaneous Quantification of six Bioactive Phenolic Acids in Roscoea purpurea Tubers and their In vitro Cytotoxic Potential against Various Cell Lines

Simultaneous Determination of 13 Constituents of Radix Polygoni Multiflori in Rat Plasma and Its Application in a Pharmacokinetic Study

A Simple and Sensitive Liquid Chromatography with Tandem Mass Spectrometric Method for the Simultaneous Determination of Anthraquinone Glycosides and Their Aglycones in Rat Plasma: Application to a Pharmacokinetic Study of Rumex acetosa Extract

Efficient Synthesis of Rottlerin and Its Two Subunits

Development and validation of a simple and rapid UPLC-MS/MS method for loganin and its application in pharmacokinetic and tissue distribution studies

Quantification of mangiferin in streptozotocin-induced diabetic rat plasma using UPLC-MS/MS: Pharmacokinetic assessment of Gentiana rhodantha extract after oral administration

A Novel Antibiotic, Rhodomyrtone: Pharmacokinetic Studies in a Murine Model and Optimization and Validation of High-Performance Liquid Chromatographic Method for Plasma Analysis

Robust high‐performance thin‐layer chromatography (HPTLC) method for stability assessment and simultaneous quantification of epigallocatechin‐3‐gallate and rosmarinic acid in lipid‐based nanoparticles and biological matrices

Target and non-target identification of chemical components in Lamiophlomis rotata by liquid chromatography/quadrupole time-of-flight mass spectrometry using a three-step protocol

Development of an Ultra-High-performance Liquid Chromatography Coupled with Triple Quadrupole Mass Spectrometry Method for Comparative Pharmacokinetics of Six Triterpenoids in Rat Plasma and Application to Different Forms of Phytolacca Acinosa.

The Pharmacological Potential of Rutin

Pharmacokinetics, plasma protein binding, and metabolism of a potential natural chemosensitizer from Marsdenia tenacissima in rats

Isolation, Cytotoxicity Evaluation and HPLC-Quantification of the Chemical Constituents from Prangos pabularia

Rottlerin, a natural polyphenol compound, inhibits upregulation of matrix metalloproteinase-9 and brain astrocytic migration by reducing PKC-δ-dependent ROS signal

Chemical and pharmacological evaluation of manglicolous lichen Roccella montagnei Bel em. D. D. Awasthi

Quantification of Desoxyrhapontigenin (4-Methoxyresveratrol) in Rat Plasma by LC–MS/MS: Application to Pre-Clinical Pharmacokinetic Study

Rutin : therapeutic potential and recent advances in drug delivery

Rottlerin suppresses lipid accumulation by inhibiting de novo lipogenesis and adipogenesis via LRP6/mTOR/SREBP1C in 3T3-L1 adipocytes